C. Brambilla (Grenoble, France), R. Pirker (Vienna, Austria)
Symptomatic pattern, alarm symptoms and diagnostic delay in a cohort of 1277 lung cancer patients
G. Buccheri, D. Ferrigno (Cuneo, Italy)
|  |
Metastatic pulmonary disease
J. V. Beli, J. L. Bushati, N. T. Thanasi (Tirana, Albania)
| |
Histopathological characteristics of lung cancer during the last 10 years
C. S. Tsobanidou, G. N. Dermitzakis, T. Jivanakis (Thessaloniki, Drama, Greece)
| |
Clinical radiological parallels of bilateral diffuse bronchoalveolar carcinoma
S. Ivanov, V. Youroukova, B. Kosturkov, M. Bogdanova, A. Gocheva, S. Angelova (Sofia, Bulgaria)
| |
Contribution of tumor markers to pretreatment staging of operable lung cancer
G. V. Nikolaev, V. K. Kossenok, G. Massard, X. Ducrocq, J. Lemaitre, R. Kessler, E. Quoix, J. M. Wihlm (Strasbourg, France)
| |
Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer
S. Singh, N. Livni, S. Pallav (London, United Kingdom)
| |
A rare type of hemorrhagic diathesis as a paraneoplastic syndrome
M. Roglic, L. Pavlovic, Z. Slobodnjak, S. Popovic-Grle, S. Zupancic-Salek (Zagreb, Croatia)
| |
Family and personal history of cancer: how common and how clinically significant is in lung cancer
G. Buccheri, D. Ferrigno (Cuneo, Italy)
| |
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer
G. Casoni, G. Cavallesco, G. Caramori, F. Ravenna, N. Calia, S. Petruzzelli, P. Boschetto, M. Saetta, A. Ciaccia, L. M. Fabbri, A. Papi (University of Padova, Italy)
| |
Association of the uteroglobin gene polymorphism with lung cancer
S. W. Um, C. M. Choi, J. J. Yim, C. G. Yoo, Y. W. Kim (Seoul, South Korea)
| |
A comparison between 2 techniques (immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH)) for her-2/neu detection in lung cancer
A. P. Meert, B. Martin, J. M. Verdebout, V. Ninane, J. P. Sculier (Brussels, Belgium)
| |
Extracts of lung cancer cells reveal the patterns of anti-tumor antibodies in sera of patients with lung cancer
A. V. Bazhin, M. S. Savchenko, O. N. Shifrina, S. Y. Chikina, A. G. Chuchalin, P. P. Philippov (Moscow, Russia)
| |
Study on the contribution of collecting techniques for cytohistologic material through the fiberbronchoscope for the diagnosis of bronchopulmonary neoplasma
F. M. Nitu, L. Ioncica, A. Voicu Maceseanu, M. Popescu Hagen, M. Nitu, G. Marasescu, M. Olteanu (Craiova, Romania)
| |
Distinct angiogenic and non-angiogenic growth patterns of lung metastases (LM) from renal cell carcinoma (RCC)
P. Sardari Nia, J. Hendriks, P. Vermeulen, E. Van Marck, P. E. Van Schil (Antwerp, Belgium)
| |
Immunopathology of advanced forms of NSCLC: the influence of induction chemotherapy
O. A. Sukhoversha (Dnipropetrovsk, Ukraine)
| |
Detection of MAGE-A expression in induced sputum and bronchial lavage fluid of patients with lung cancer
I. Mecklenburg, D. F. Stratakis, R. M. Huber, K. Häussinger, A. Morresi-Hauf, G. Riethmueller, P. Kufer (Munich, Germany)
| |
Tumor-specific mRNA in cell-free bronchial lavage supernatant - new possibilities in lung cancer diagnosis
B. Schmidt, E. Engel, T. Carstensen, U. Liebers, M. John, M. Fleischhacker, C. Witt (Berlin, Germany)
| |
The prognostic value of altered pRb and p53 protein expression in non-small cell lung cancer
D. Dworakowska, E. Jassem, R. Dworakowski, K. Wiedorn, C. Boltze, J. Skokowski, K. Jaskiewicz, E. Czestochowska, A. Bosse, J. Jassem (Gdansk, Poland; Stuttgart, Magdeburg, Germany)
| |
The prognostic significance of sVEGF levels in patients(pts) with Non-small cell lung cancer (NSCLC)
I. Danos, G. S. Dionellis, A. J. Karayiannakis, A. G. Charpidou, F. Scotti, H. Karapanagiotou, K. N. Syrigos (Athens, Greece)
| |
The detection of quantitative serum p53 protein in lung cancer and its clinical value
E. Sen, U. Gonullu, N. Akar, S. Dizbay Sak (Ankara, Turkey)
| |